The TSX Venture 50 is an annual ranking of the top performing companies from the past year on TSXV based on three equally weighted criteria: market capitalization growth, share price appreciation and ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...

Partnership to drive subscription and transaction revenue through a revenue share modelNew York, NY, Feb. 19, 2025 (GLOBE NEWSWIRE) -- MMA.INC ...

Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...